The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome

Sohag University

Status: Not yet enrolling

Conditions: Polycystic Ovary Syndrome

Study type: Observational

Funder types: Other

Identifiers

NCT05929950

soh-med-23-06-04MD

Details and patient eligibility

About

The goal of the study is to detect autoantibodies in the serum of the women with PCOS and evaluate the obesity markers to investigate the the role of autoimmunity and obesity in PCOS

Enrollment: 90 estimated patients

Sex: Female

Ages: 12 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• patients diagnosed with PCOS according to the Rotterdam (2003) criteria.

Exclusion criteria

• Patients with other causes of hyperandrogenism as congenital adrenal hyperplasia, androgen-secreting tumors, Cushing's syndrome, hyperprolactinemia, virilizing ovarian or adrenal tumors and those taking drugs affecting insulin resistance, such as estrogens, oral contraceptives and corticosteroids during the previous three months before the study.

Trial design

90 participants in 2 patient groups

patients with PCOS

control group